Here is how Beam Therapeutics Inc. (BEAM) and Aurora Cannabis Inc. (ACB) have performed compared to their sector so far this year.

Blue Trust Inc. increased its position in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 36.3% during the ...

He revealed, “The aim of radiation therapy is to deliver a precise measured dose of radiation to a defined tumour volume with ...

BMO Capital Markets reaffirmed their Outperform rating on Beam Therapeutics Inc (NASDAQ:BEAM), with a steady price target of $57.00. Currently trading at $26.57, the stock appears undervalued ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

At the age of 16, Alex Arkell went to the doctors after she noticed her stomach was bloated and painful during a holiday, but ...

Alex Arkell was just 16-years-old when she suffered from painful stomach bloating that was later diagnosed as an extremely ...

To help minimize radiation dose to the heart it was decided that the best treatment approach was deep inspiration breath hold (DIBH) with SGRT using VitalHold.

CRISPR Therapeutics CRSP is expected to report fourth-quarter and full-year 2024 earnings later this month. The Zacks ...

Proton therapy is taking a significant step forward in Southwest Florida with the addition of a new medical director to the team.

It has been around a year since Beam Therapeutics slashed its headcount and R&D programmes to focus mainly on a sickle cell disease candidate – and the biotech has now revealed the first data ...